Abbott CA 19-9XR assay set - Taiwan Registration ab7bf1bfa717fea06f68c51c7d7f7927
Access comprehensive regulatory information for Abbott CA 19-9XR assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ab7bf1bfa717fea06f68c51c7d7f7927 and manufactured by FUJIREBIO DIAGNOSTICS, INC.;; ABBOTT GmbH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including FUJIREBIO DIAGNOSTICS, INC.;; ABBOTT GMBH, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
ab7bf1bfa717fea06f68c51c7d7f7927
DHA05603147306
Product Details
This product is a chemical cold light microparticle enzyme immunoassay (CMIA) with the Alinity i analyzer to quantitatively test 1116-NS-19-9 reaction determinants in human serum or plasma.
A Clinical Chemistry and Clinical Toxicology;; C Immunology and Microbiology
C.6010 Mass phase antigen immunoassay system;; A.1660 Grade Material (Analysis Material Non-Analysis);; A.1150 Calibrated Products
Contract manufacturing;; input
Dates and Status
Sep 19, 2018
Sep 19, 2028